TD ASSET MANAGEMENT INC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 47 filers reported holding RELMADA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$75,000
+143.9%
25,000
+100.0%
0.00%
Q2 2023$30,750
+8.8%
12,5000.0%0.00%
Q1 2023$28,250
-35.2%
12,5000.0%0.00%
Q4 2022$43,625
-90.3%
12,5000.0%0.00%
-100.0%
Q3 2022$452,000
+98.2%
12,500
+4.2%
0.00%
Q2 2022$228,0000.0%12,000
+41.9%
0.00%
Q1 2022$228,000
-9.9%
8,455
+30.2%
0.00%
Q4 2019$253,0006,4930.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders